Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia

Authors

Srdan Verstovsek, MD Anderson Cancer Center
Ruben Mesa, Mayo Clinic
Moshe Talpaz, University of Michigan-Ann Arbor
Jean-Jacques Kiladjian, Universite Paris Diderot
Claire N. Harrison, Guy's and St Thomas' NHS Foundation Trust
Stephen T. Oh, Washington University School of Medicine in St. Louis
Alessandro M. Vannucchi, University of Florence
Raajit Rampal, Memorial Sloan Kettering Cancer Center
Bart L. Scott, Fred Hutchinson Cancer Research Center
Sarah A. Buckley, CTI BioPharma Inc.
Adam R. Craig, CTI BioPharma Inc.
Karisse Roman-Torres, CTI BioPharma Inc.
John O. Mascarenhas, Icahn School of Medicine at Mount Sinai

Journal

Haematologica

Publication Date

7-1-2022

Volume

107

Issue

7

First Page

1599

Last Page

1607

Document Type

Open Access Publication

DOI

10.3324/haematol.2021.279415

Rights and Permissions

Verstovsek S, Mesa R, Talpaz M, Kiladjian JJ, Harrison CN, Oh ST, Vannucchi AM, Rampal R, Scott BL, Buckley SA, Craig AR, Roman-Torres K, Mascarenhas JO. Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia. Haematologica. 2022 Jul 1;107(7):1599-1607. doi: 10.3324/haematol.2021.279415. ©2022 Ferrata Storti Foundation Haematologica material is published under a CC-BY-NC license.

Recommended Citation

Verstovsek, Srdan; Mesa, Ruben; Talpaz, Moshe; Kiladjian, Jean-Jacques; Harrison, Claire N.; Oh, Stephen T.; Vannucchi, Alessandro M.; Rampal, Raajit; Scott, Bart L.; Buckley, Sarah A.; Craig, Adam R.; Roman-Torres, Karisse; and Mascarenhas, John O., "Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia." Haematologica. 107, 7. 1599 - 1607. (2022).
https://digitalcommons.wustl.edu/oa_4/247